Arrowgrass Capital Partners (US)’s Thermo Fisher Scientific TMO Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,000	Closed	-$1.14M	–	442
2017 Q4	$1.14M	Buy	6,000 +5,940	+9,900%	+$1.14M	0.01%	428
2017 Q3	$1.14M	Hold	60	–	–	0.01%	491
2017 Q2	$1.05M	Sell	60 -163	-73%	-$27.4K	0.01%	522
2017 Q1	$3.42M	Buy	223 +139	+165%	+$21.2K	0.04%	369
2016 Q4	$1.19M	Hold	84	–	–	0.01%	414
2016 Q3	$1.34M	Hold	84	–	–	0.02%	337
2016 Q2	$1.24M	Sell	84 -116	-58%	-$17.1K	0.01%	321
2016 Q1	$2.83M	Sell	200 -341	-63%	-$45.7K	0.03%	240
2015 Q4	$7.67M	Buy	+541	New	+$72.2K	0.09%	127

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s TMO Position: Q3 2017 in Review

Arrowgrass Capital Partners (US) sold out of Thermo Fisher Scientific (TMO) in Q3 2017, closing a stake of 17,661 shares — an estimated $3.2M sold.

Arrowgrass Capital Partners (US) first reported a position in TMO in Q3 2013 and held it in 6 quarters. The position peaked at $11.2M in Q3 2014. 1,162 funds tracked by Wall St. Rank hold TMO as of Q3 2017.

Arrowgrass Capital Partners (US) reported no remaining Thermo Fisher Scientific position as of Q3 2017 after selling out during the quarter.
Arrowgrass Capital Partners (US) sold 17,661 Thermo Fisher Scientific shares in Q3 2017, an estimated $3.2M.
Arrowgrass Capital Partners (US) first reported a position in Thermo Fisher Scientific in Q3 2013 and held it in 6 quarters.
Arrowgrass Capital Partners (US)'s Thermo Fisher Scientific position peaked at $11.2M in Q3 2014.
1,162 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2017.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2017, filed 14 Nov 2017.